Quest Diagnostics Inc. priced a $500 million aggregate principal amount of 5.000% senior notes due 2036 on April 27, 2026. The company expects to receive the net proceeds upon closing on May 6, 2026, subject to customary closing conditions.
Proceeds will be used for general corporate purposes, including the repayment of a $500 million aggregate principal amount of 3.45% senior notes maturing June 1, 2026. The refinancing moves the company from a shorter‑dated, lower‑coupon debt to a longer‑dated, higher‑coupon instrument, reflecting the current interest‑rate environment and the company’s strategy to extend its debt maturity profile.
The debt issuance follows a strong Q1 2026 earnings report in which Quest Diagnostics posted revenue of $2.90 billion, up 9.2% from $2.65 billion in Q1 2025, and adjusted diluted earnings per share of $2.50, up 13.1% from $2.21 in Q1 2025. The growth was driven by organic revenue gains across physician, hospital, and consumer channels, and by volume expansion from key partnerships with Fresenius Medical Care and Corewell Health.
Management highlighted the earnings beat and raised full‑year 2026 guidance, citing robust demand and disciplined cost control. The company’s CEO, Jim Davis, noted that the company’s “more than 9% revenue growth, almost entirely organic, and approximately 13% adjusted diluted earnings per share growth reflect our team’s disciplined execution of our strategy to deliver innovative diagnostic solutions for our customers’ evolving needs.”
The new notes carry a 5.000% coupon, higher than the 3.45% coupon on the notes being refinanced, and are rated Baa1 by Moody’s and BBB+ by S&P and Fitch. The issuance provides Quest Diagnostics with financial flexibility to support growth initiatives, potential acquisitions, and operational investments while maintaining an investment‑grade credit profile.
Overall, the pricing of the senior notes demonstrates Quest Diagnostics’ proactive approach to capital structure management, balancing the need for liquidity with the goal of extending debt maturities in a rising‑rate environment.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.